QBioMed has the global exclusive rights to develop and market a novel chemotherapeutic drug to treat liver cancer.
Technology Ventures News
Pet Rx: Can human health research benefit our four-legged friends?
Health advancements made at OMRF could translate to better health for your pets.
OMRF hosts national biotechnology forum
Visiting attendees represented some of the top names in in the industry.
Eisai, OMRF enter autoimmune disease research collaboration
The project is focused on lupus, which affects up to 1.5 million Americans.
Tech Ventures team adds two
Sam McNeal, Ph.D., and Michael Sweeney have joined the Technology Ventures staff.
OMRF, Biogen enter autoimmune disease collaboration
Goal: to deliver new and better treatment options to patients
